WHO ICTRP trial

An open clinical trial on teh efficacy of H-AL pollens (Grass mixture I)…

EUCTR2004-001521-19-CZ · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2004-001521-19-CZ
Public title An open clinical trial on teh efficacy of H-AL pollens (Grass mixture I) administered orally and sublingually in patients with indicated allergen immunotherapy (AIT) with Type I allergy mediated by IgE antibodies (pollens allergy), enrolled in the clinical trial according to the protocol MS01092001 - -
Scientific title An open clinical trial on teh efficacy of H-AL pollens (Grass mixture I) administered orally and sublingually in patients with indicated allergen immunotherapy (AIT) with Type I allergy mediated by IgE antibodies (pollens allergy), enrolled in the clinical trial according to the protocol MS01092001…
Primary sponsor SEVAPHARMA a.s.
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Countries Czech Republic
Conditions Type I allergy to pollens mediated by IgE antibodies
Interventions Trade Name: H-Al Pollens Smes trav I per os Product Name: H-Al pollens Smes trav I per os Pharmaceutical Form: Oral drops, solution
Registration date Aug 20, 2004
Target size 72
Secondary IDs MS04062004
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations